Cargando…

Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling

Ebolaviruses Bundibugyo virus (BDBV) and Ebola virus (EBOV) cause fatal hemorrhagic disease in humans and nonhuman primates. While the host response to EBOV is well characterized, less is known about BDBV infection. Moreover, immune signatures that mediate natural protection against all ebolaviruses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woolsey, Courtney, Borisevich, Viktoriya, Agans, Krystle N., Fenton, Karla A., Cross, Robert W., Geisbert, Thomas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406165/ https://www.ncbi.nlm.nih.gov/pubmed/34372693 http://dx.doi.org/10.1128/mBio.01517-21

Ejemplares similares

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
por: Cross, Robert W., et al.
Publicado: (2021)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W., et al.
Publicado: (2020)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
por: Kuang, Erin, et al.
Publicado: (2022)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
por: Cross, Robert W., et al.
Publicado: (2020)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
por: Woolsey, Courtney, et al.
Publicado: (2023)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Immune correlates of postexposure vaccine protection against Marburg virus
por: Woolsey, Courtney, et al.
Publicado: (2020)

Establishment of an African green monkey model for COVID-19
por: Woolsey, Courtney, et al.
Publicado: (2020)

Establishment of an African green monkey model for COVID-19 and protection against reinfection
por: Woolsey, Courtney, et al.
Publicado: (2020)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
por: Mire, Chad E., et al.
Publicado: (2016)

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Geisbert, Thomas W., et al.
Publicado: (2021)

Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model
por: Satterfield, Benjamin A., et al.
Publicado: (2019)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
por: Mire, Chad E, et al.
Publicado: (2020)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2019)

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2017)

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses
por: Daaboul, George G., et al.
Publicado: (2017)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
por: Mire, Chad E, et al.
Publicado: (2013)

The immunomodulating V and W proteins of Nipah virus determine disease course
por: Satterfield, Benjamin A., et al.
Publicado: (2015)

Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication
por: Olsen, Michelle E., et al.
Publicado: (2016)

Combination therapy protects macaques against advanced Marburg virus disease
por: Cross, Robert W., et al.
Publicado: (2021)

Molecular analysis of the 2012 Bundibugyo virus disease outbreak
por: Hulseberg, Christine E., et al.
Publicado: (2021)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
por: Zeitlin, Larry, et al.
Publicado: (2021)

Correction for Olsen et al., “Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication”
por: Olsen, Michelle E., et al.
Publicado: (2018)

Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda
por: MacNeil, Adam, et al.
Publicado: (2010)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k4vk0lcdmlftj94fahdib2q9f0